BridgeBio Pharma Inc
BBIO76.300USD
+2.160+2.91%
Close 12/19, 16:00（ET）Quotes delayed by 15 min
14.70BMarket Cap
LossP/E TTM
BridgeBio Pharma Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
221.90M
2285.27%
EPS(YoY)
-2.88
27.13%
Analyst Rating
BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its total revenue reached 221.90M, with a year-on-year change of 2285.27%.
What is the Earnings Per Share (EPS) of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -2.879, with a year-on-year change of 27.13%.
What is the net income of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its net income was -535.76M, with a year-on-year change of 16.70%.
What is the net margin of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its net profit margin was -244.86%, with a year-on-year change of 96.51%.
What is the gross margin of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its gross margin was 98.25%, with a year-on-year change of 33.30%.
What is the debt-to-asset ratio of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its debt-to-asset ratio was 239.35%, with a year-on-year change of -24.26%.
What is the Return on Equity (ROE) of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its Return on Equity (ROE) was --, with a year-on-year change of --.
What is the Return on Assets (ROA) of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its Return on Assets (ROA) was -74.14%, with a year-on-year change of 33.64%.
What is the operating profit of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its operating profit was -577.37M, with a year-on-year change of 3.68%.
What are the current assets of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its current assets were 720.69M, with a year-on-year change of 50.90%.
What are the total assets of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its total assets of BridgeBio Pharma Inc were 919.34M, with a year-on-year change of 68.26%.
What are the total liabilities of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its total liabilities of BridgeBio Pharma Inc were 2.38B, with a year-on-year change of 25.84%.
What is the total equity of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its total equity of BridgeBio Pharma Inc was -1.46B, with a year-on-year change of -8.57%.
What is the net operating income of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its net operating income of BridgeBio Pharma Inc was -543.35M, with a year-on-year change of 16.82%.
What is the net investment of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its net investment of BridgeBio Pharma Inc was 60.78M, with a year-on-year change of 12.49%.
What is the net financing of BridgeBio Pharma Inc?
According to BridgeBio Pharma Inc's FY2024 earnings report, its net financing of BridgeBio Pharma Inc was 748.46M, with a year-on-year change of 65.76%.
